UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Xarelto results in fewer strokes and systemic emboli for frail NVAF patients: study
A new study shows Xarelto (ingredient: rivaroxaban) to result in fewer stro...
by Marian Chu
|
2018-06-01 12:09
라인
Teva Handok gets reimbursement for narcolepsy drug
Teva Handok’s once-daily narcolepsy therapy Nuvigil (ingredient: armodafini...
by Marian Chu
|
2018-06-01 12:06
라인
Korea United Pharm wages war on Chinese fake capsules
Korea United Pharm said it would seek compensation for damages against a Ch...
by So Jae-hyeon
|
2018-06-01 12:05
라인
YUHS, Celltrion to develop next-generation stroke therapy
Researchers from Yonsei University Health System (YUHS) will work with Cell...
by Marian Chu
|
2018-05-31 18:01
라인
Novartis Korea launches 2nd generation acromegaly therapy
Signifor LAR (pasireotide pamoate) Source: Korea Pharmaceutical Informati...
by Marian Chu
|
2018-05-31 17:48
라인
Leo Pharma Korea launches Enstilum foam for psoriasis
Enstilum foam Leo Pharma Korea has launched a spray-on, topical treatment...
by Marian Chu
|
2018-05-31 17:47
라인
OCI enters pharma sector via joint venture with Bukwang
Chemicals and energy firm OCI has announced that it would enter the pharmac...
by So Jae-hyeon
|
2018-05-31 15:38
라인
Viromed confirms VM202’s nerve regeneration effect
Viromed said Wednesday that it has conducted a study to confirm that VM202 ...
by Lee Han-soo
|
2018-05-31 14:15
라인
Procedures of genetic therapy Invossa exceed 1,000 cases
Kolon Life Science and Mundipharma Korea said on Wednesday that the number ...
by So Jae-hyeon
|
2018-05-31 14:14
라인
HanAll unveils P2 results on dry eye treatment
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Wednesday ...
by Lee Han-soo
|
2018-05-31 13:10
라인
AbbVie to challenge Gilead on hepatitis C front in Korea
AbbVie Korea’s winning of reimbursement for its hepatitis C treatment Mavyr...
by Marian Chu
|
2018-05-30 16:28
라인
Huons wins patent for dry eye treatment in China
Huons said Wednesday that it has acquired a patent regarding the manufactur...
by Lee Han-soo
|
2018-05-30 14:28
라인
Gemvax & KAEL's benign prostatic hyperplasia treatment draws interest
Gemvax & Kael said Monday that the Nature Reviews Urology, an international...
by Lee Han-soo
|
2018-05-29 20:57
라인
Chong Kun Dang to co-market Eisai’s dementia treatment
Chong Kun Dang CEO Kim Young-joo (left) and Eisai Korea CEO Ko Hong-byung s...
by Lee Han-soo
|
2018-05-29 16:37
라인
Eli Lilly aims for migraine injection to touch down in Korea in 2019
New injections to prevent migraines with little or no side effects are now ...
by Marian Chu
|
2018-05-29 16:05
라인
Novo Nordisk Korea issues weight loss data of Saxenda
Novo Nordisk Korea published real-world study findings on its obesity treat...
by Marian Chu
|
2018-05-29 11:16
라인
Some drugs remain blockbusters even after patent expiration. Why?
What does hair loss treatment Propecia, cholesterol therapy Lipitor, and he...
by Marian Chu
|
2018-05-29 11:16
라인
US cancer institute to fund Genexine’s cancer research
Genexine and NeoImmuneTech said last Friday that the National Cancer Instit...
by Lee Han-soo
|
2018-05-28 15:22
라인
Jeil to market Pharma Research Product’s eye drop
Jeil Healthscience, a subsidiary of Jeil Pharmaceutical, said Monday that i...
by Lee Han-soo
|
2018-05-28 15:19
라인
Novartis Korea gets additional indication for Revolade
Novartis Korea’s Revolade (ingredient: eltrombopag) can now be used to trea...
by Marian Chu
|
2018-05-28 12:00
-
이전
81
82
83
84
85
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top